“Science and Technology Innovation Board Daily”, Feb. 23 — The main contents of today's Science and Technology Innovation Board Evening News include: the Securities Regulatory Commission held its first offline press conference in the Year of the Dragon. Currently, there are no plans for a 10-year IPO backcheck, which will greatly increase the proportion of on-site inspections of companies to be listed; the Science and Technology Innovation 50 Index was adjusted regularly in the first quarter to transfer to 3 stocks of Jinghe Integrated, Artes, and Aviation Materials; Jingjin Electric: Obtaining the target for a three-in-one electric drive assembly project in the European market from a leading global vehicle customer.

[Focus on hot topics]

Securities Regulatory Commission: Currently, there are no arrangements for a 10-year IPO backcheck, which will greatly increase the proportion of on-site inspections of companies to be listed

The China Securities Regulatory Commission held its first offline press conference in the Year of the Dragon on February 23. Yan Bojin, chief risk officer of the CSRC and director of the issuance department, responded to the “Ten Years of IPO Investigation” market rumor. Yan Bojin said that preventing and cracking down on financial fraud and fraudulent distribution is a continuous process, and there are currently no plans to reverse an IPO for 10 years. In the issuance and listing supervision work, the Securities Regulatory Commission is continuing to strengthen full-chain checks, strictly investigate and severely punish financial fraud and fraudulent issuance. It will also greatly increase the proportion of on-site inspections of companies to be listed, and the improvement in the quality of listed companies will respond to investors' concerns.

Yan Bojin, chief risk officer of the Securities Regulatory Commission and director of the issuance department, said that the CSRC system insists on putting investors first, strictly reviewing companies to be listed, severely punishing acts that violate laws and regulations and infringe on investors' interests, using the deterrent power of supervision to make enterprises afraid to “break through customs with illness” and improve the quality of listed companies at the source. After a company goes public, financial authenticity remains a top priority in daily supervision. The Securities Regulatory Commission system comprehensively uses various methods such as regular reporting and supervision, on-site inspections, etc., to circularly screen high-risk suspicious companies, find cases of financial fraud and fraudulent issuance, and refer serious cases to the public security authorities for criminal liability. “It can be said that whether it is a proposed company under review or a company that has already been listed, no matter when it was listed, it must continue to be strictly supervised by the Securities Regulatory Commission.” he said.

Li Ming, chief inspector of the Securities Regulatory Commission and director of the Inspection Bureau, said that manipulating the market through human manipulation to distort stock prices, causing stock prices to skyrocket and plummet, and mislead investors' trading decisions. After making a profit and leaving the market, leaving behind a “scammer,” the essence of this is “fraud”; in insider trading, a small number of people grasp insider information, take advantage of trading first, and seize more profit opportunities. The essence of this is “stealing.” In response, the Securities Regulatory Commission will establish a “penetrating” lead screening system through multi-dimensional technical means such as comprehensive monitoring, big data collision, multi-channel collection, and intelligent analysis to accurately identify and severely crack down on market manipulation and insider trading.

The Science and Technology Innovation 50 Index was adjusted regularly in the first quarter to transfer 3 stocks of Jinghe Integrated Technology, Artes, and Aviation Materials Co., Ltd.

The reporter learned that the Shanghai Stock Exchange and China Securities Index Co., Ltd. decided to adjust the Science Innovation 50 Index sample in the first quarter, which will take effect after the market closes on March 8, 2024. Three individual stocks were transferred this time, including Crystal Integration, Artes, and Aviation Materials Co., Ltd. In addition, there are 5 alternative stocks for the Science Innovation 50 Index, namely Shenzhou Cell-U, Weijie Chuangxin, Yandongwei, Fluorite Network, and Autoway. The Science Innovation 50 Index consists of 50 securities with large market capitalization and good liquidity in the Science and Technology Innovation Board. It reflects the overall performance of the most market-representative group of science and innovation enterprises. According to the index compilation rules, samples of science and innovation indices such as Science Innovation 50 are adjusted regularly every quarter. The reporter noticed that 10 securities, including Zhongke Fei Test, XinDong Lianke, and Vmax, will also be transferred to the Science and Technology Innovation 100 Index. After this sample adjustment, both index representation and sample quality have improved. According to the data, the total market value of the adjusted Science and Technology Innovation 50 Index was 2.2 trillion yuan, up 1.2 percentage points from before the adjustment. The total market value of the Science and Technology Innovation 100 Index was 1.3 trillion yuan, up 1.3 percentage points from before the adjustment. The total market capitalization coverage rate of the Science Innovation 50 and Science Innovation 100 Index has reached 68.1%, which together well characterizes the performance of large and medium market capitalization securities on the Science and Technology Innovation Board.

The product scale of the Science and Technology Innovation Index continues to grow, and the total scale has reached 172.4 billion yuan

The reporter noticed that the Science Innovation 50, Science and Technology Innovation 100, and other science and technology innovation indices are important tools for investors to seize investment opportunities in the hard technology industry, and the scale of domestic products continues to grow. According to the data, as of February 19, the total product scale of the Science and Technology Innovation Index reached 172.4 billion yuan. The flagship index Science Innovation 50 products reached 139.4 billion yuan. The current products include 10 domestic ETFs listed on the Shanghai Stock Exchange, 4 OTC index funds, and 6 linked funds. Another enhanced strategy ETF is being raised, and 13 products have been successively listed on exchanges in 7 countries and regions, including the US, the United Kingdom, and Japan. It is one of the A-share indices with the largest number of overseas products. The product scale of the Science and Technology Innovation 100 Index, which reflects the overall performance of medium-sized listed companies on the Science and Technology Innovation Board, reached 25.9 billion yuan, an increase of 94% over the initial launch scale. The eight ETF products continued to attract net capital inflows after their launch. It is the latest emerging index with the largest product scale and the fastest growth rate recently. In addition, the science and innovation industry and strategy index reached 14 domestic products, with a product scale of 7.1 billion yuan.

Depth:

AI is changing the film and television industry The first Wensheng video animation is coming

Yuanchen Technology's financing market has repeatedly hit regulatory red, and the online stock exchange twice during the year suggests the risk of financing transactions

10 rounds of financing! Gao Wei, Shenzhen Venture Capital, and Renfu Pharmaceutical have all invested in another CRO company that “raises monkeys” to go public

OPPO and vivo suspend vertical folding screen research and development? The latest response is here!

[Science and Technology Innovation Board Announcement]

Fangyuan Co., Ltd., Nanxin Technology, etc. plan to be repurchased

Fangyuan Co., Ltd. announced that it plans to repurchase shares for 50 million yuan to 100 million yuan, with a repurchase price of no more than 8.26 yuan/share.

Nanxin Technology announced that it plans to repurchase shares for 50 million yuan to 100 million yuan, and the share repurchase price will not exceed 44 yuan/share.

Chipboard announced that it plans to repurchase shares for 30 million yuan to 60 million yuan. The repurchase price will not exceed RMB 76 per share.

Kexon Pharmaceuticals announced that it plans to repurchase shares for 30 million yuan to 60 million yuan, with a repurchase price of no more than 26.08 yuan/share.

Huiyu Pharmaceutical announced that it plans to repurchase shares for 30 million yuan to 60 million yuan, and the repurchase price of shares will not exceed 18.31 yuan/share.

Actual controllers of Sanyou Medical and Gete Biotech plan to increase their holdings

Jet Biotech announced that Yuan Jianhua, the controlling shareholder, one of the actual controllers and chairman, plans to increase the company's shares by 5 million yuan to 10 million yuan.

Sanyou Medical announced that one of the actual controllers of the company plans to increase its holdings by 4 million yuan to 6 million yuan.

Huahong Company, Liyang Chip, etc. disclose quick performance reports

Jingjin Electric: Obtaining the target position for a three-in-one electric drive assembly project in the European market from a leading global vehicle customer

Jingjin Electric announced that the company recently obtained a target for a three-in-one electric drive assembly project from a leading global vehicle customer through bidding and signed a related supply contract with it. The company was selected for a three-in-one electric drive assembly project in the European market by one of the world's leading automotive customers. The company will supply three-in-one electric drive assemblies in batches to the vehicle customer's European vehicle assembly plant to support its pure electric passenger vehicle platform. The development cycle is 3 years, the expected official batch production time is 2027, and the project product life cycle is 6 years.

[Venture capital weather vane]

Guangzi Technology received hundreds of millions of yuan in Series D financing

Guangzi Technology recently completed Series D financing of hundreds of millions of yuan. The investors are 37 Mutual Entertainment Venture Capital Fund, Shenzhen Investment Holdings, and Zhongan Capital. Guangzi Technology is a high-speed analog optoelectronic chip developer. It is committed to developing and industrializing optoelectronic integrated chips and systems used in 5G transmission, 3D sensing, and lidar.